1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Summary statistics of mean and maximum rCBV values, KPS, and PFS of the 3 subgroups of the patient population
rCBVmeanrCBVmaxKPS, Median (range)PFS (average in days)
Astrocytomas (n = 27)3.5 (±2.7)3.7 (±2.7)90 (50–100)576 (±505)
Oligodendrogliomas (n = 4)3.1 (±2.2)3.3 (±2.0)90 (70–100)942 (±566)
Oligoastrocytomas (n= 3)2.4 (±1.7)2.9 (±2.3)90 (70–90)1030 (±401)